Clora is an intelligent platform founded in 2016 that specializes in matching life science companies with flexible, on-demand expertise. The platform leverages proprietary algorithms to connect companies with highly qualified consultants for specialized projects in the pharmaceutical, biotechnology, and medical device sectors. Clora provides a faster and more cost-efficient alternative to traditional recruitment methods, offering access to a global network of life science professionals with decades of experience from top companies like Merck, Pfizer, Johnson & Johnson, and Novartis.
Clora was founded in 2016 by industry veterans who had firsthand experience with the challenges of staffing life science projects. The company is headquartered in Cambridge, Massachusetts, and has grown steadily since its inception. The founders built the platform to address the inefficiencies and high costs associated with traditional staffing models in the life sciences industry. By 2024, Clora had grown to employ around 29 people and generated approximately $4 million in annual revenue.
Clora has raised a total of $4.76 million in funding through various rounds, including seed investments. While exact valuation figures are not publicly available, estimates from Dealroom.co suggest that Clora's enterprise valuation was between $13 million and $20 million as of December 2017. The company continues to operate at the seed stage as it scales its operations.
Clora’s core offering is its intelligent talent-matching platform, which allows life science companies to post projects and receive up to three vetted candidates who meet their specific requirements within days. Key features include:
Global Network Access: Clora provides access to a global pool of life science consultants with expertise across various therapeutic areas.
Proprietary Algorithm: The platform uses AI-driven algorithms to match companies with consultants based on factors like skills, experience, location, and availability.
There is no public information indicating that Clora has made any acquisitions or expanded its product offerings beyond its core talent-matching platform.
Clora’s primary innovation lies in its use of AI-driven algorithms for matching talent with projects. While no specific new features have been announced recently, the platform’s ability to provide tailored matches within days remains a key differentiator from traditional recruitment methods.
Clora's culture is rooted in solving real-world problems faced by life science companies when staffing projects. The company values efficiency, flexibility, and cost-effectiveness. Its mission is to reduce the time and cost associated with finding specialized talent while maintaining high-quality matches. The focus on helping life sciences organizations innovate faster by providing them with the right expertise reflects a customer-centric approach.
Clora serves a wide range of clients within the life sciences industry, including major pharmaceutical companies like Merck, Pfizer, Johnson & Johnson, Novartis, as well as regulatory bodies like the FDA. While specific user numbers are not disclosed, Clora has built a reputation for providing high-quality matches quickly and efficiently. Its user base likely consists of small biotech startups as well as large pharmaceutical firms looking for specialized talent on a project-by-project basis.
